Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bronchipret TP
- Development stage
- Unknown
- Lead developer
- Bionorica
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Bronchipret TP is a herbal medicinal product (phytopharmaceutical) developed by Bionorica SE for the treatment of acute bronchitis and colds characterized by productive cough and viscous mucus. It is formulated as film-coated tablets containing a fixed combination of thyme herb dry extract (*Thymus vulgaris* or *Thymus zygis*) and primula root extract (*Primula veris* or *Primula elatior*). The drug exerts anti-inflammatory and secretolytic effects, specifically by inhibiting the influx of polymorphonuclear (PMN) cells into the lungs and reducing the expression of mucin 5AC (MUC5AC) protein. It is indicated for adults and adolescents aged 12 years and older and has been evaluated in Phase 4 clinical trials in Germany to confirm its efficacy and tolerability in treating acute bronchitis with productive cough.
- Brand names
- Bronchipret TP
- Other names
- Bronchipret TP film-coated tablets
02
Targets
GABRR (GABA-A receptor subunit rho)MUC5AC (Mucin-5AC)ALOX12 (Arachidonate 12-lipoxygenase, 12S type)
Beyond the preview
Go deeper on Bronchipret TP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bronchipret TP.